Mallouppas, M;
Walker, JM;
Guha, A;
Dobson, R;
Ghosh, AK;
(2020)
Cardio-oncology for the general physician: 'old' and 'new' cardiovascular toxicities and how to manage them.
British Journal of Hospital Medicine
, 81
(9)
10.12968/hmed.2020.0269.
Preview |
Text
CO review.pdf - Published Version Download (56kB) | Preview |
Abstract
Cardio-oncology is the care of cancer patients with cardiovascular disease. The need for a dedicated subspecialty emerged to address heart failure caused by drugs such as anthracyclines and anti-human epidermal growth factor receptor 2 (HER2) therapies, but over time has expanded into an exciting subspecialty with widening horizons. While still dealing with a lot of commonly recognised toxicities, such as heart failure, hypertension and coronary disease, new and revolutionary cancer therapies have been associated with challenging cardiovascular complications, requiring specialist input to manage effectively. Echocardiography is a key investigation, with advanced techniques such as three-dimensional and strain assessment allowing more accurate diagnosis and earlier detection of subtle changes. Cardiac magnetic resonance and biomarkers are useful adjuncts to aid diagnosis and management. With increasing cancer incidence and improved cancer survival rates, it is important that general cardiologists and physicians are aware of cardiac complications associated with cancer and how to manage them.
| Type: | Article |
|---|---|
| Title: | Cardio-oncology for the general physician: 'old' and 'new' cardiovascular toxicities and how to manage them |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.12968/hmed.2020.0269 |
| Publisher version: | https://doi.org/10.12968/hmed.2020.0269 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Cancer, Cardio-oncology, Cardiotoxicity, Heart failure, Myocarditis, Toxicity, CANCER-THERAPY, BREAST-CANCER, CARDIOTOXICITY, DYSFUNCTION, RADIATION, MECHANISMS, CONSENSUS, DISEASE |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10139956 |
Archive Staff Only
 |
View Item |
